Development, High-Throughput Profiling, and Biopanning of a Large Phage Display Single-Domain Antibody Library
- PMID: 38732011
- PMCID: PMC11083953
- DOI: 10.3390/ijms25094791
Development, High-Throughput Profiling, and Biopanning of a Large Phage Display Single-Domain Antibody Library
Abstract
Immunoglobulin G-based monoclonal antibodies (mAbs) have been effective in treating various diseases, but their large molecular size can limit their penetration of tissue and efficacy in multifactorial diseases, necessitating the exploration of alternative forms. In this study, we constructed a phage display library comprising single-domain antibodies (sdAbs; or "VHHs"), known for their small size and remarkable stability, using a total of 1.6 × 109 lymphocytes collected from 20 different alpacas, resulting in approximately 7.16 × 1010 colonies. To assess the quality of the constructed library, next-generation sequencing-based high-throughput profiling was performed, analyzing approximately 5.65 × 106 full-length VHH sequences, revealing 92% uniqueness and confirming the library's diverse composition. Systematic characterization of the library revealed multiple sdAbs with high affinity for three therapeutically relevant antigens. In conclusion, our alpaca sdAb phage display library provides a versatile resource for diagnostics and therapeutics. Furthermore, the library's vast natural VHH antibody repertoire offers insights for generating humanized synthetic sdAb libraries, further advancing sdAb-based therapeutics.
Keywords: antibody library; next-generation sequencing; phage display; single-domain antibody.
Conflict of interest statement
Dr. Taehoon Ryu and Yushin Jung were employed by ATG Lifetech Inc. The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
References
-
- Quinteros D.A., Bermúdez J.M., Ravetti S., Cid A., Allemandi D.A., Palma S.D. Nanostructures for Drug Delivery. Elsevier; Amsterdam, The Netherlands: 2017. Chapter 25—Therapeutic use of monoclonal antibodies: General aspects and challenges for drug delivery; pp. 807–833.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
